Follicular fluid and mural granulosa cells microRNA profiles vary in in vitro fertilization patients depending on their age and oocyte maturation stage
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Quiñonero A
- Martínez S
- de la Orden M
- Domínguez F
Grupos
Abstract
Objective: To determine whether there is any difference in the follicular fluid (FF) microRNA (miRNA) profiles from in vitro fertilization (IVF) patients according to their age and oocyte maturation stage. Design: Observational prospective study. Setting: IVF clinic/hospital facilities. Patients(s): We included 30 women with primary infertility undergoing intracytoplasmic sperm injection treatment and excluded patients with polycystic ovarian syndrome, endometriosis, severe male factor, and low ovarian reserve. Intervention(s): After the collection of FF and granulosa cells from each patient, the samples were processed for total RNA extraction. RNA was pooled into different groups (three samples per pool) for microarray analysis to evaluate the expression of a total of 866 human miRNAs. Individual samples were analyzed to validate the pooled microarray results using real-time polymerase chain reaction. Main Outcome Measure(s): Evaluation of the expression of a total of 866 human miRNAs in FF and granulosa cells. Result(s): We identified only one differentially expressed miRNA, hsa-miR-424, which is present in higher proportions in FF from patients with advanced age. When we compared the FF from metaphase II (MII) versus GV (germinal vesicle) oocytes, we found 13 differentially expressed miRNAs (two up-and 11 downregulated). When we compared FF from MII versus MI, we found seven differentially expressed miRNAs in MII (three up-and four downregulated). Conclusion(s): We have described the FF miRNA profiles according to IVF patients' age and the maturation stage of their oocytes. This descriptive study may aid our understanding of the physiology and regulation of oocyte maturation and could identify some potential miRNA biomarkers for this process. (C)2015 by American Society for Reproductive Medicine.
Datos de la publicación
- ISSN/ISSNe:
- 0015-0282, 1556-5653
- Tipo:
- Article
- Páginas:
- 1037-1037
- PubMed:
- 26209829
- Factor de Impacto:
- 2,278 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
FERTILITY AND STERILITY ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 47
Documentos
- No hay documentos
Filiaciones
Keywords
- Follicular fluid; miRNA; oocytes; granulosa cells; biomarker
Proyectos y Estudios Clínicos
ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA
Investigador Principal: ANTONIO PELLICER MARTÍNEZ
PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL
CD11/00292 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL
CD12/00568 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
CONTRATO POST FSE (RIO HORTEGA)
CM13/00191 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014
ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARA EVALUAR SEGURIDAD Y EFICACIA DE ELAGOLIX EN PARTICIPANTES CON DOLOR MODERADO O SEVERO ASOCIADO A ENDOMETRIOSIS.
Investigador Principal: VICENTE PAYÁ AMATE
M12-671
EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF ELAGOLIX IN SUBJECTS WITH MODERATE TO SEVERE ENDOMETRIOSIS-ASSOCIATED PAIN. / ESTUDIO DE EXTENSIÓN PARA EVALUAR LA SEGURIDAD Y LA EFICACIA A LARGO PLAZO DE ELAGOLIX EN PARTICIPANTES CON DOLO R DE MODERADO A SEVERO ASOCIADO A ENDOMETRIOSIS.
Investigador Principal: VICENTE PAYÁ AMATE
M12-821 . 2014
Cita
MORENO JM,NÚÑEZ MJ,Quiñonero A,Martínez S,de la Orden M,SIMÓN C,PELLICER A,DÍAZ C,Domínguez F. Follicular fluid and mural granulosa cells microRNA profiles vary in in vitro fertilization patients depending on their age and oocyte maturation stage. Fertil Steril. 2015. 104. (4):p. 1037-1037. IF:4,426. (1).